Sonoma Pharmaceuticals
SNOA | NASDAQ
$0.88
-$0.21 (-19.27%)
At close: Nov 16, 2026, 4:00 PM ET
$0.88
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-19.27%
(1D)Rating
46.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #359/1021 (Top 35%)
Key Statistics
Market Data
Market Cap $4.46M
1D Range
0.82 1.08
52W Range
0.82 3.80
Valuation (TTM)
PE -0.97
PB 0.67
EV/EBITDA -0.51
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $0.00
Cash Flow
FCF Yield -62.6%
SBC Adj. FCF Yield -68.4%
SBC Impact -9.4%
Margins
Gross Margin 39.2%
Operating Margin -3.3%
FCF Margin -11.9%
Growth (CAGR)
Revenue 3Y | 5Y 24.7% |
10.1%
Dil EPS 3Y | 5Y 73.3% |
58.8%
FCF 3Y | 5Y -108.5% |
29.9%
Returns
ROA -10.5%
ROE -36.4%
ROIC -6.0%
Financial Health
Net Cash
$4.55M
Current Ratio 3.48
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, includin...
Sector Healthcare
Employees 10
IPO Date Jan 25, 2007
Website www.sonomapharma.com
Fiscal Year April - March
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
$0.09
Beat +190.00%
YoY:
+128.13% REV
$7.17M
Beat +35.61%
YoY:
+28.02%Next Earnings
Feb 16, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove SNOA